Technology

Aldeyra Therapeutics

$12.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.50 (+4.24%) Today
+$0.15 (+1.22%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALDX and other stocks, options, and ETFs commission-free!

About ALDX

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA. The listed name for ALDX is Aldeyra Therapeutics, Inc. Common Stock.

CEO
Todd C. Brady
Employees
20
Headquarters
Lexington, Massachusetts
Founded
2004
Market Cap
584.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.47M
High Today
$12.48
Low Today
$11.91
Open Price
$12.36
Volume
1.23M
52 Week High
$14.62
52 Week Low
$1.48

Collections

ALDX News

Benzinga17h

Notable Insider Buys Of The Past Week: Affirm, HEICO, Vector Group, Biotechs And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders have been taking advantage of secondary

ALDX Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

MITT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure